Ed Mathers
New Enterprise Associates Partner
investment range
$200k - $40.0m
sweet spot
$10.0m
Ed Mathers's Past Investments (19)
| Company | Deal Type | Amount | Date | |
|---|---|---|---|---|
| Akouos | Seed Round | $7.5M (Lead) | Nov 2017 | |
| Trevi Therapeutics | Series C | $50.5M (Lead) | Jul 2017 | |
| Synlogic | Series C | $42M | May 2017 | |
| Mirna Therapeutics | Series D | $41.8M | Apr 2015 | |
| Synlogic | Series A | $29.4M (Lead) | Jul 2014 | |
| Lumena Pharmaceuticals | Series B | $45M (Lead) | Mar 2014 | |
| Lumos Pharma | Series A | $14M (Lead) | Feb 2014 | |
| Motus Therapeutics | Series B | $8M | Nov 2012 | |
| Intarcia Therapeutics | Series C | $160M | Nov 2012 | |
| Intarcia Therapeutics | Debt Financing | $50M | Nov 2012 |
Ed Mathers's Experience
Partner New Enterprise Associates2008 - Present
Partner New Enterprise Associates (NEA)2008 - Present
Ed Mathers's Education
NC State University Bachelor of Science (BS)
Ed Mathers's Media
No media found for Ed Mathers.